A peculiar constellation of tau pathology defines a subset of dementia in the elderly
暂无分享,去创建一个
Miklós Palkovits | Herbert Budka | Gabor G. Kovacs | Angelika Reiner-Concin | M. Palkovits | H. Budka | P. Fischer | G. Kovacs | Selma Hönigschnabl | Peter Fischer | A. Reiner-Concin | Thomas Ströbel | T. Ströbel | S. Hönigschnabl | Kinga Molnár | Lajos László | Gergö Botond | K. Molnár | G. Botond | L. Laszlo | Gergö Botond
[1] Dennis W Dickson,et al. Progressive Supranuclear Palsy: Pathology and Genetics , 2007, Brain pathology.
[2] D. Dickson,et al. Neuropathology of variants of progressive supranuclear palsy. , 2010, Current opinion in neurology.
[3] H. Budka,et al. Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics , 2010, Acta Neuropathologica.
[4] John L. Robinson,et al. Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. , 2010, Archives of neurology.
[5] David R Williams,et al. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges , 2009, The Lancet Neurology.
[6] J. Trojanowski,et al. Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology , 2010, Annals of neurology.
[7] M. Esiri,et al. Haplotype-specific expression of exon 10 at the human MAPT locus. , 2006, Human molecular genetics.
[8] L. Hazrati,et al. Neuropathology and genetics of corticobasal degeneration. , 2008, Handbook of clinical neurology.
[9] D. Bennett,et al. The neuropathology of older persons with and without dementia from community versus clinic cohorts. , 2009, Journal of Alzheimer's disease : JAD.
[10] M. Yamada,et al. Early‐stage progressive supranuclear palsy with degenerative lesions confined to the subthalamic nucleus and substantia nigra , 2011, Neuropathology : official journal of the Japanese Society of Neuropathology.
[11] H. Braak,et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.
[12] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[13] H. Arai,et al. Concurrence of TDP-43, tau and α-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies , 2007, Brain Research.
[14] W. Krampla,et al. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia , 2007, Neurology.
[15] K. Davis,et al. Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease , 2006, Neurology.
[16] A. Delacourte,et al. Diffuse form of argyrophilic grain disease: a new variant of four-repeat tauopathy different from limbic argyrophilic grain disease , 2003, Acta Neuropathologica.
[17] D. Neary,et al. TDP-43 in ubiquitinated inclusions in the inferior olives in frontotemporal lobar degeneration and in other neurodegenerative diseases: a degenerative process distinct from normal ageing , 2009, Acta Neuropathologica.
[18] Dennis W. Dickson,et al. Alzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of &agr;-Synucleinopathy , 2006, Journal of neuropathology and experimental neurology.
[19] David A. Bennett,et al. Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.
[20] C. Lemere,et al. Regional distribution of TDP‐43 inclusions in Alzheimer disease (AD) brains: Their relation to AD common pathology , 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.
[21] J. Trojanowski,et al. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. , 2006, The American journal of pathology.
[22] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[23] A. Delacourte,et al. Neurofibrillary Degeneration in Progressive Supranuclear Palsy and Corticobasal Degeneration , 1999, Journal of neurochemistry.
[24] C. Brayne,et al. Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge city over-75s cohort (CC75C) study. , 2009, Journal of Alzheimer's disease : JAD.
[25] H. Akiyama,et al. Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies , 2009, Acta Neuropathologica.
[26] T. Iwatsubo,et al. A clinical and neuropathological study of an unusual case of sporadic tauopathy. A variant of corticobasal degeneration? , 2002, Neuroscience Letters.
[27] H. Budka,et al. Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases. , 2010, Clinical neuropathology.
[28] A. Lees,et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. , 2007, Brain : a journal of neurology.
[29] A. Probst,et al. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease , 1999, Acta Neuropathologica.
[30] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[31] K. Jellinger,et al. Prevalence of dementia disorders in the oldest-old: an autopsy study , 2010, Acta Neuropathologica.
[32] P. Lantos,et al. Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration , 2002, Journal of neuropathology and experimental neurology.
[33] A. Lees,et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation. , 2010, Brain : a journal of neurology.
[34] Y. Hirayasu,et al. Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease , 2009, Acta Neuropathologica.
[35] D. Hanger,et al. Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N‐terminally cleaved tau containing four microtubule‐binding repeats , 2008, Journal of neurochemistry.
[36] Shinji Ohara,et al. Corticobasal degeneration with focal, massive tau accumulation in the subcortical white matter astrocytes , 2006, Acta Neuropathologica.
[37] William T. Hu,et al. Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease , 2008, Acta Neuropathologica.
[38] H. Akiyama,et al. Glial Tau Pathology in Neurodegenerative Diseases: Their Nature and Comparison with Neuronal Tangles , 1998, Neurobiology of Aging.
[39] M. Tolnay,et al. Argyrophilic grain disease: A late‐onset dementia with distinctive features among tauopathies , 2004, Neuropathology : official journal of the Japanese Society of Neuropathology.
[40] I Litvan,et al. Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.
[41] D W Dickson,et al. Widespread cytoskeletal pathology characterizes corticobasal degeneration. , 1995, The American journal of pathology.
[42] H. Braak,et al. Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria , 1998, Journal of Neural Transmission.
[43] Kit-Yi Leung,et al. Novel Phosphorylation Sites in Tau from Alzheimer Brain Support a Role for Casein Kinase 1 in Disease Pathogenesis* , 2007, Journal of Biological Chemistry.
[44] John L. Robinson,et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases , 2007, Acta Neuropathologica.
[45] J. Hodges,et al. Phosphorylation of soluble tau differs in Pick’s disease and Alzheimer’s disease brains , 2009, Journal of Neural Transmission.
[46] S. Murayama,et al. Staging of Argyrophilic Grains: An Age‐Associated Tauopathy , 2004, Journal of neuropathology and experimental neurology.
[47] A. Delacourte,et al. Tau protein as a differential biomarker of tauopathies. , 2005, Biochimica et biophysica acta.
[48] Julie S. Snowden,et al. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype , 2006, Acta Neuropathologica.
[49] G Forster,et al. Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study. , 2009, Brain : a journal of neurology.
[50] J. Trojanowski,et al. Concomitant TAR-DNA-Binding Protein 43 Pathology Is Present in Alzheimer Disease and Corticobasal Degeneration but Not in Other Tauopathies , 2008, Journal of neuropathology and experimental neurology.
[51] E. Bigio,et al. Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy , 2010, Acta Neuropathologica.
[52] J. Cummings. Toward a molecular neuropsychiatry of neurodegenerative diseases , 2003, Annals of neurology.
[53] A. Kakita,et al. Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: a variant of corticobasal degeneration? , 2005, Acta Neuropathologica.
[54] J. Trojanowski,et al. Nitration of tau protein is linked to neurodegeneration in tauopathies. , 2003, The American journal of pathology.
[55] J. Schneider,et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration , 2007, Acta Neuropathologica.
[56] R. Mohs,et al. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.
[57] Isidre Ferrer,et al. Delineation of Early Changes in Cases with Progressive Supranuclear Palsy‐Like Pathology. Astrocytes in Striatum are Primary Targets of Tau Phosphorylation and GFAP Oxidation , 2009, Brain pathology.